The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

HOUSSIAU, F.; VASCONCELOS, C.; D'CRUZ, D.; SEBASTIANI, G.; DE RAMON GARRIDO, E.; DANIELI, M.; Abramovicz, D.; BLOCKMANS, D.; CAULI, A.; Direskeneli, H.; GALEAZZI, M.; Guel, Ahmet; LEVY, Y.; PETERA, P.; POPOVIC, R.; PETROVIC, R.; SINICO, R.; CATTANEO, R.; FONT, J.; DEPRESSEUX, G.; COSYNS, J-P; CERVERA, R.

doi:10.1136/ard.2008.102533

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

HOUSSIAU F. A., VASCONCELOS C., D'CRUZ D., SEBASTIANI G. D., DE RAMON GARRIDO E., DANIELI M. G., ...Daha Fazla

ANNALS OF THE RHEUMATIC DISEASES, cilt.69, sa.1, ss.61-64, 2010 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 69 Sayı: 1
Basım Tarihi: 2010
Doi Numarası: 10.1136/ard.2008.102533
Dergi Adı: ANNALS OF THE RHEUMATIC DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.61-64
İstanbul Üniversitesi Adresli: Evet

Özet

Objective: To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) cyclophosphamide (CY) followed by azathioprine (AZA) as treatment for proliferative lupus nephritis.